Clinical Trial Update: FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period

View source ↗

Summary

Real-life evaluation of darifenacin (Enablex) for overactive bladder in South Africa over a 3-month period; the FREEDOM study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Enablex (darifenacin)

Snippet

Sponsor: Bayer | Conditions: Overactive Bladder | Status: COMPLETED